- Home
- TS vs HOLX Comparison
TS vs HOLX Comparison
Compare TS & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TS
- HOLX
- Stock Information
- Founded
- TS 2001
- HOLX 1985
- Country
- TS Luxembourg
- HOLX United States
- Employees
- TS N/A
- HOLX N/A
- Industry
- TS Steel/Iron Ore
- HOLX Medical Electronics
- Sector
- TS Industrials
- HOLX Health Care
- Exchange
- TS Nasdaq
- HOLX Nasdaq
- Market Cap
- TS 17.9B
- HOLX 12.1B
- IPO Year
- TS N/A
- HOLX 1990
- Fundamental
- Price
- TS $33.45
- HOLX $62.17
- Analyst Decision
- TS Buy
- HOLX Hold
- Analyst Count
- TS 6
- HOLX 13
- Target Price
- TS $43.33
- HOLX $76.27
- AVG Volume (30 Days)
- TS 1.5M
- HOLX 5.0M
- Earning Date
- TS 07-30-2025
- HOLX 07-28-2025
- Dividend Yield
- TS 4.96%
- HOLX N/A
- EPS Growth
- TS N/A
- HOLX 25.36
- EPS
- TS 1.63
- HOLX 2.39
- Revenue
- TS $12,004,602,000.00
- HOLX $4,026,500,000.00
- Revenue This Year
- TS N/A
- HOLX $2.97
- Revenue Next Year
- TS $0.04
- HOLX $4.75
- P/E Ratio
- TS $9.95
- HOLX $26.01
- Revenue Growth
- TS N/A
- HOLX 1.66
- 52 Week Low
- TS $27.24
- HOLX $51.90
- 52 Week High
- TS $40.87
- HOLX $84.67
- Technical
- Relative Strength Index (RSI)
- TS 47.83
- HOLX 61.50
- Support Level
- TS $32.00
- HOLX $53.62
- Resistance Level
- TS $34.42
- HOLX $68.25
- Average True Range (ATR)
- TS 0.55
- HOLX 2.19
- MACD
- TS 0.04
- HOLX 0.98
- Stochastic Oscillator
- TS 46.62
- HOLX 58.44
About TS Tenaris S.A.
Tenaris is one of the largest global producers of oil country tubular goods, which are used primarily in the construction of oil and gas wells. Its production facilities are located primarily in the US, Argentina, Mexico, and Italy. Tenaris' premium OCTG products are among the most trusted by oil companies for use in the most challenging applications, including deep-water offshore wells and horizontal shale wells.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.